IMPROVED SURVIVAL DURATION WITH COMBINATION CHEMOTHERAPY INDUCTION FOR MULTIPLE-MYELOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY

被引:87
|
作者
DURIE, BGM
DIXON, DO
CARTER, S
STEPHENS, R
RIVKIN, S
BONNET, J
SALMON, SE
DABICH, L
FILES, JC
COSTANZI, JJ
机构
[1] UNIV ARIZONA,ARIZONA MED CTR,TUCSON,AZ 85724
[2] SW ONCOL GRP,CTR BIOSTAT,HOUSTON,TX
[3] UNIV KANSAS,MED CTR,KANSAS CITY,KS 66103
[4] PUGET SOUND ONCOL CONSORTIUM,SEATTLE,WA
[5] SCOTT & WHITE CLIN,TEMPLE,TX
[6] UNIV MICHIGAN,ANN ARBOR,MI 48109
[7] UNIV MISSISSIPPI,MED CTR,JACKSON,MS 39216
[8] UNIV TEXAS,MED BRANCH,GALVESTON,TX 77550
关键词
D O I
10.1200/JCO.1986.4.8.1227
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1227 / 1237
页数:11
相关论文
共 50 条
  • [1] ALTERNATING COMBINATION CHEMOTHERAPY AND LEVAMISOLE IMPROVES SURVIVAL IN MULTIPLE-MYELOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    SALMON, SE
    HAUT, A
    BONNET, JD
    AMARE, M
    WEICK, JK
    DURIE, BGM
    DIXON, DO
    JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (08) : 453 - 461
  • [2] CHEMOTHERAPY IS SUPERIOR TO SEQUENTIAL HEMIBODY IRRADIATION FOR REMISSION CONSOLIDATION IN MULTIPLE-MYELOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    SALMON, SE
    TESH, D
    CROWLEY, J
    SAEED, S
    FINLEY, P
    MILDER, MS
    HUTCHINS, LF
    COLTMAN, CA
    BONNET, JD
    CHESON, B
    KNOST, JA
    SAMHOURI, A
    BECKORD, J
    STOCKNOVACK, D
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (09) : 1575 - 1584
  • [3] PHASE-II TRIAL OF MITOXANTRONE IN MULTIPLE-MYELOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    ALBERTS, DS
    BALCERZAK, SP
    BONNET, JD
    STEPHENS, RL
    CANCER TREATMENT REPORTS, 1985, 69 (11): : 1321 - 1323
  • [4] PHASE-II STUDY OF FLUDARABINE PHOSPHATE IN MULTIPLE-MYELOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    KRAUT, EH
    CROWLEY, JJ
    GREVER, MR
    KEPPEN, MD
    BONNET, JD
    HYNES, HE
    SALMON, SE
    INVESTIGATIONAL NEW DRUGS, 1990, 8 (02) : 199 - 200
  • [5] PHASE-II EVALUATION OF BISANTRENE IN REFRACTORY MULTIPLE-MYELOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    DURIE, BGM
    CROWLEY, J
    COLTMAN, CA
    CHAPMAN, RA
    BALCERZK, SP
    BONNET, JD
    LIPSCHITZ, DA
    STEPHENS, RL
    CHESON, BD
    INVESTIGATIONAL NEW DRUGS, 1991, 9 (04) : 329 - 331
  • [6] IMPROVED SURVIVAL IN MULTIPLE-MYELOMA WITH COMBINATION CHEMOTHERAPY AND PLASMAPHERESIS
    WAHLIN, A
    HOLM, J
    NYSTROM, L
    HAEMATOLOGIA, 1984, 17 (04) : 465 - 471
  • [7] COMBINATION CHEMOTHERAPY, GLUCOCORTICOIDS, AND INTERFERON-ALFA IN THE TREATMENT OF MULTIPLE-MYELOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    SALMON, SE
    CROWLEY, JJ
    GROGAN, TM
    FINLEY, P
    PUGH, RP
    BARLOGIE, B
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (11) : 2405 - 2414
  • [8] SEQUENTIAL COMBINATION CHEMOTHERAPY FOR DISSEMINATED MELANOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    COSTANZI, J
    FABIAN, C
    WILSON, H
    DIXON, D
    CANCER TREATMENT REPORTS, 1981, 65 (7-8): : 732 - 734
  • [9] PHASE-II TRIAL OF DIAZIQUONE IN PATIENTS WITH REFRACTORY AND RELAPSING MULTIPLE-MYELOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    STUCKEY, WJ
    CROWLEY, J
    BAKER, LH
    LARRIMER, NR
    HANSON, KH
    BONNET, JD
    WHITE, LA
    CANCER TREATMENT REPORTS, 1987, 71 (11): : 1095 - 1096
  • [10] ACLACINOMYCIN-A IN THE TREATMENT OF MULTIPLE-MYELOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    KARANES, C
    CROWLEY, J
    SAWKAR, L
    TRANUM, BL
    HICKS, WJ
    BONNET, JD
    DABICH, L
    DANA, BW
    SALMON, S
    INVESTIGATIONAL NEW DRUGS, 1990, 8 (01) : 101 - 104